Atlas Trials

Quelling of Excitotoxicity in Acute Stroke With Ketamine

Clinical trial NCT03223220 · NOT_YET_RECRUITING

Trial details

NCT number
NCT03223220
Sponsor
Lower Merion Neurology Research Foundation
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acute Ischemic Stroke
Start date
2024-07-01
Primary completion
2026-12-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.